within Pharmacolibrary.Drugs.ATC.M;

model M03AB01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0006666666666666666,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00020999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03AB01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Suxamethonium (succinylcholine) is a depolarizing neuromuscular blocking agent used to induce muscle relaxation and short-term paralysis, typically for facilitation of tracheal intubation and during surgical procedures. It acts by mimicking acetylcholine at the neuromuscular junction, leading to sustained depolarization. It is still approved and widely used today in emergency and anaesthesia settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult individuals after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Duvaldestin, P (1981). Pharmacokinetics in intravenous anaesthetic practice. <i>Clinical pharmacokinetics</i> 6(1) 61–82. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198106010-00003&quot;>10.2165/00003088-198106010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6113908/&quot;>https://pubmed.ncbi.nlm.nih.gov/6113908</a></p></li><li><p>Meistelman, C, &amp; Fuchs-Buder, T (2009). [Pharmacology of sugammadex]. <i>Annales francaises d&#x27;anesthesie et de reanimation</i> 28 Suppl 2 S51–S56. DOI:<a href=&quot;https://doi.org/10.1016/S0750-7658(09)72488-8&quot;>10.1016/S0750-7658(09)72488-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19887278/&quot;>https://pubmed.ncbi.nlm.nih.gov/19887278</a></p></li><li><p>Torda, TA, et al., &amp; Donohue, P (1997). Pharmacokinetics and pharmacodynamics of suxamethonium. <i>Anaesthesia and intensive care</i> 25(3) 272–278. DOI:<a href=&quot;https://doi.org/10.1177/0310057X9702500312&quot;>10.1177/0310057X9702500312</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9209610/&quot;>https://pubmed.ncbi.nlm.nih.gov/9209610</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03AB01;
